Chronic lymphocytic leukemia

Dis Mon. 2012 Apr;58(4):153-67. doi: 10.1016/j.disamonth.2012.01.009.
No abstract available

Publication types

  • Review

MeSH terms

  • Age Distribution
  • Antineoplastic Agents / therapeutic use
  • B-Lymphocytes / pathology
  • Biopsy, Fine-Needle
  • Bone Marrow / pathology
  • Chromosome Deletion
  • Environmental Exposure / adverse effects
  • Gene Deletion
  • Genetic Predisposition to Disease
  • Glomerulonephritis, Membranoproliferative / etiology
  • Hematopoietic Stem Cell Transplantation
  • Hepatomegaly / etiology
  • Humans
  • Immunoglobulins / blood
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
  • Leukemia, Lymphocytic, Chronic, B-Cell / epidemiology
  • Leukemia, Lymphocytic, Chronic, B-Cell / etiology
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Lymphatic Diseases / etiology
  • Lymphocytosis / etiology
  • Neoplasm Staging
  • Prognosis
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Racial Groups
  • Sex Distribution
  • Skin Diseases, Papulosquamous / etiology
  • Splenectomy
  • Splenomegaly / etiology
  • Tumor Virus Infections / complications
  • Watchful Waiting
  • beta 2-Microglobulin / blood

Substances

  • Antineoplastic Agents
  • Immunoglobulins
  • Proto-Oncogene Proteins c-bcl-2
  • beta 2-Microglobulin